Press Release

BioAgilytix Celebrates Jenn Zemo as 2025 Triangle Business Journal Women in Business Award Winner 

Durham, NC – [2025] – BioAgilytix, a global leader in bioanalytical services, is proud to celebrate its commitment to inclusivity and excellence with Jenn Zemo, Global Leader for Quality and Regulatory, being named a 2025 Triangle Business Journal Women in Business Award Winner. Women make up over 60% of BioAgilytix’s global workforce, exemplifying the company’s dedication to fostering diversity in science. 

Jenn has been instrumental in driving quality and regulatory compliance at BioAgilytix since joining in 2013. Her leadership has supported the company’s involvement in over 30% of FDA biologics approvals in the past five years, alongside initiatives that enhance global collaboration, scientific training, and operational efficiencies across the company’s seven global locations. 

“Jenn’s leadership and innovation are shining examples of the talent within BioAgilytix,” said Davide Molho, CEO of BioAgilytix. “Her recognition highlights the power of diverse perspectives in shaping the future of healthcare and advancing scientific discovery.” 

BioAgilytix supports drug development at every phase, offering PK, immunogenicity, biomarker, and CMC analytical testing services. Each year, the company develops over 800 assays and processes over 1,200,000 patient samples at its labs in the U.S., Australia, and Germany. 

“It’s an honor to be recognized alongside so many inspiring women,” Jenn shared. “This award highlights the incredible culture we’ve built at BioAgilytix and our collective mission to improve patients’ lives.” 

About BioAgilytix

BioAgilytix is the trusted partner for bioanalytical services throughout every phase of the drug development process. As a leading global bioanalytical laboratory, the company provides established and emerging pharmaceutical and biotechnology organizations with pharmacokinetic (PK), immunogenicity, biomarker, and CMC analytical testing services in a GxP environment. BioAgilytix maintains state-of-the-art laboratories in Durham, North Carolina; Boston, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia; and Hamburg, Germany. For more information, please visit www.bioagilytix.com

For more information, please contact:

Noelle Brawner
Communications Manager
BioAgilytix Labs, LLC
Noelle.brawner@bioagilytix.com